COMMUNIQUÉS West-GlobeNewswire

InstaLipo™ Reduces Stubborn Fat Non-Surgically!
29/01/2018
New York City, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Are you struggling to lose those extra inches off your waist, hips, thighs, or buttocks? NYC plastic surgeon Dr. Sharon Giese is now offering InstaLipo™ – the latest non- [...]
Ritter Pharmaceuticals Appoints Diane J. Plotkin as Vice President of Clinical Development, Ahead of the Launch of its Phase 3 Clinical Trial
29/01/2018
LOS ANGELES, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutics that modulate the human gut microbiome to treat [...]
Innovation Pharmaceuticals Brilacidin Franchise Anchored in Three Clinical Indications — Oral Mucositis, Inflammatory Bowel Disease and Serious Skin Infections; Expands into Dermatologic Diseases
29/01/2018
BEVERLY, Mass., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provides a business development update: The Confidential [...]
Sun Biopharma, Inc. Announces Initiation of First-Line Combination Study of Sbp-101 With Gemcitabine and Nab-Paclitaxel in Patients With Pancreatic Cancer
29/01/2018
MINNEAPOLIS, Jan. 29, 2018 (GLOBE NEWSWIRE) -- – Sun BioPharma, Inc. (OTCQB:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic diseases, today announced [...]
DiaMedica to Present at the 14th Annual Noble Investor Conference
29/01/2018
MINNEAPOLIS, Jan. 29, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (TSXV:DMA) (OTCQB:DMCAF), today announced that Mr. Rick Pauls, its President and CEO, will present at Noble Capital Markets’ Fourteenth Annual [...]
Abeona Receives FDA Regenerative Medicine Advanced Therapy Designation for EB-101 Gene Therapy in Epidermolysis Bullosa
29/01/2018
First gene therapy RMAT designation for Epidermolysis Bullosa Enables accelerated approval path and real world data usage NEW YORK and CLEVELAND, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO [...]
Hemispherx to Present at the BIO CEO & Investor Conference
29/01/2018
ORLANDO, Fla., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), focused on pharmaceutical research, announced today that it will be presenting at the BIO CEO & Investor Conference on [...]
Adamas Announces Closing of Its Public Offering of Common Stock, and Full Exercise of Underwriters’ Option to Purchase Additional Shares
29/01/2018
EMERYVILLE, Calif., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced the closing of its previously announced underwritten public offering of its common stock. Adamas sold 3, [...]
Ultragenyx Appoints Camille L. Bedrosian, M.D. as Chief Medical Officer and Executive Vice President
29/01/2018
NOVATO, Calif., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]
Bellerophon Therapeutics Announces Enrollment Exceeds 100 Patients in Phase 3 INOvation-1 Study Evaluating INOpulse® for Treatment of Pulmonary Arterial Hypertension
29/01/2018
WARREN, N.J., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ), a clinical-stage biotherapeutics company, today announced that enrollment in its Phase 3 INOvation-1 study evaluating [...]
China Oncology Focus Limited Receives Approval by Chinese Authorities to Begin Clinical Trials in Three Separate Cancer Indications Using Sorrento’s Anti-PD-L1 Monoclonal Antibody
29/01/2018
HONG KONG and SAN DIEGO, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Effective January 29th, 2018, Lee’s Pharm and Sorrento Therapeutics announce that the Chinese authorities have approved China Oncology Focus Limited (COF, an [...]
Rexahn Pharmaceuticals Receives Notice of Allowance for A New U.S. Patent Covering the Use of RX-5902 (Supinoxin™)
29/01/2018
ROCKVILLE, Md., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, [...]
Cidara Therapeutics Announces Presentations at the 8th Advances Against Aspergillosis Conference and 2018 BMT Tandem Meeting
29/01/2018
SAN DIEGO, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that data from preclinical [...]
PositiveID Corporation Publishes White Paper and Data on its Successful Detection of Influenza Virus
29/01/2018
DELRAY BEACH, Fla., Jan. 29, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that it has published a [...]
Pernix Announces Patent Litigation Settlement Agreement with Actavis Concerning Zohydro® ER
29/01/2018
MORRISTOWN, N.J., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, today announced that it has entered into a settlement agreement with Actavis [...]
Cellectar Initiates DLBCL Cohort in Phase 2 Trial of CLR 131 in Refractory B-Cell Hematologic Cancers
29/01/2018
MADISON, Wis., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]
Evogene to Participate in Israeli Consortium to Develop Phenotyping Tools and Systems for Precision Agriculture
29/01/2018
REHOVOT, Israel, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ: EVGN ) (TASE: EVGN ), a leading biotechnology company developing novel products for life science markets through the use of a unique computational [...]
HempAmericana CEO Issues Letter to Shareholders
29/01/2018
NEW YORK, Jan. 29, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) CEO issues the following letter to Shareholders Dear Valued Shareholder, The purpose of [...]
XORTX Therapeutics Announces Appointment of Allan Williams and Paul Van Damme
29/01/2018
CALGARY, Alberta, Jan. 29, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX), a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney [...]

Pages